Table 3.
Number of use reports (URs), number of species, CI, and FIC values for each medicinal use categorya
| Medicinal use categories | Georgia | Turkey | ||||||
|---|---|---|---|---|---|---|---|---|
| ♯ UR (%) | ♯ of spp. | CI | FIC | ♯ UR (%) | ♯ of spp. | CI | FIC | |
| Skin | 163 (19.31%) | 45 | 3.62 | 0.73 | 193 (29.15%) | 47 | 2.61 | 0.76 |
| Digestive | 203 (24.05%) | 51 | 4.51 | 0.75 | 128 (19.34%) | 44 | 1.73 | 0.66 |
| Respiratory | 105 (12.44%) | 37 | 2.33 | 0.65 | 75 (11.33%) | 34 | 1.01 | 0.55 |
| Cardiovascular | 100 (11.85%) | 50 | 2.22 | 0.51 | 69 (10.42%) | 37 | 0.93 | 0.47 |
| Muscle-skeletal | 73 (8.65%) | 25 | 1.62 | 0.67 | 58 (8.76%) | 22 | 0.78 | 0.63 |
| Genitourinary | 69 (8.18%) | 35 | 1.53 | 0.50 | 55 (8.31%) | 34 | 0.74 | 0.39 |
| Ghus | 56 (6.64%) | 37 | 1.24 | 0.35 | 23 (3.47%) | 20 | 0.31 | 0.14 |
| Endocrine | 39 (4.62%) | 24 | 0.87 | 0.39 | 35 (5.29%) | 22 | 0.47 | 0.38 |
| Neurological | 11 (1.30%) | 10 | 0.24 | 0.10 | 11 (1.66%) | 10 | 0.15 | 0.10 |
| Psychological | 15 (1.78%) | 5 | 0.33 | 0.71 | 2 (0.30%) | 2 | 0.03 | – |
| Blood | 6 (0.71%) | 4 | 0.13 | 0.40 | 7 (1.06%) | 7 | 0.09 | – |
| Eye | 4 (0.47%) | 3 | 0.09 | 0.33 | 4 (0.60%) | 3 | 0.05 | 0.33 |
| Ear | – | 4 | – | – | 2 (0.30%) | 2 | 0.03 | – |
| Total | 844 (100%) | 126b | 18.8 | 662 (100%) | 109b | 8.95 | 0.76 | |
aUse categories were ranked in accordance of importance based on mean CI values
bAs some species are cited in more than one use categories, these numbers (126 and 109) indicating the number of species recorded in Turkey and in Georgia are lower than the total of number of species recorded for each medicinal use category